Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis.
Atherosclerosis shares many similarities with inflammatory and autoimmune diseases, among them rheumatoid arthritis (RA). Anticardiolipin antibodies (aCL) and antibodies against beta2-glycoprotein I (anti-beta2GPI) have been detected in sera of RA patients in several studies. We demonstrated aCL and anti-beta2GPI in a selected group of 70 patients with RA (premenopausal women, non-diabetic, non-hypertensive) and compared them with age- and sex-matched controls. There was a significant higher internal carotid artery intima-media thickness and number of plaques in RA patients compared to controls. aCL of IgG and IgM classes were present in 15.7% of RA patients as compared to 5% in the control group. Thirty percent of RA patients had anti-beta2GPI of IgG, IgM and IgA classes compared to 7.5% in controls. Major differences were seen in IgG and IgA classes. Our results support the idea that aCL and anti-beta2GPI represent an important risk factor for atherosclerosis in RA patients. Elevated levels of phosphatidylserine-dependent antiprothrombin antibodies did not contribute significantly to the general prevalence of antiphospholipid antibodies.
Pahor
Artur
A
Teaching Hospital, Maribor, Slovenia.
Hojs
Radovan
R
Holc
Iztok
I
Ambrozic
Ales
A
Cucnik
Sasa
S
Kveder
Tanja
T
Rozman
Blaz
B
D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood*; D050197:Atherosclerosis / Q000209:etiology*; D002339:Carotid Arteries / Q000473:pathology; D002340:Carotid Artery Diseases / Q000209:etiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D017697:Premenopause; D012307:Risk Factors
D017152:Antibodies, Antiphospholipid